Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chorea

K M Shannon1

  • 1Department of Neurological Sciences, Rush-Presbyterian-St. Luka's Medical Center, Chicago, IL 60612, USA.

Current Opinion in Neurology
|August 1, 1996
PubMed
Summary
This summary is machine-generated.

Huntington's disease is linked to brain protein expression, but the cause of damage remains unclear. Genetic testing aids in studying early disease changes and identifying rare chorea causes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ras oncogene-independent activation of RALB signaling is a targetable mechanism of escape from NRAS(V12) oncogene addiction in acute myeloid leukemia.

Oncogene·2016
Same author

Elucidating Genetic Counseling Outcomes from the Perspective of Genetic Counselors.

Journal of genetic counseling·2016
Same author

Impaired compensation for mechanical loads in a patient with hemiballismus following stroke.

Parkinsonism & related disorders·2008
Same author

Effect of donepezil on motor and cognitive function in Huntington disease.

Neurology·2006
Same author

Successful treatment of eosinophilic pleural effusions following congenital heart surgery.

Pediatric cardiology·2006
Same author

Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia.

Neurology·2005
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Area of Science:

  • Neuroscience
  • Genetics
  • Neurology

Background:

  • Huntington's disease (HD) involves widespread brain expression of a specific mutation and its protein product.
  • The precise mechanism linking this expression to excitotoxic brain damage is not fully understood.
  • The advent of genetic testing for HD has spurred research into preclinical changes and the diagnosis of rare choreiform disorders.

Purpose of the Study:

  • To explore the expression of the Huntington's disease mutation and protein in the brain.
  • To investigate the potential link between this expression and excitotoxic damage.
  • To understand the role of genetic testing in studying preclinical HD and identifying other causes of chorea.

Main Methods:

  • Review of existing literature on Huntington's disease genetics and neuropathology.

Related Experiment Videos

  • Analysis of studies investigating preclinical changes in Huntington's disease.
  • Examination of case reports and research on rare choreic illnesses and basal ganglia dysfunction.
  • Main Results:

    • The Huntington's disease mutation and its protein product are demonstrably widespread throughout the brain.
    • A definitive causal link to excitotoxic damage has not yet been established.
    • Genetic testing has facilitated earlier detection of disease-related changes and the recognition of diverse etiologies for chorea.

    Conclusions:

    • While the Huntington's disease mutation and protein are broadly expressed in the brain, the mechanism of associated damage requires further elucidation.
    • Genetic testing has proven valuable for understanding early disease trajectories and differentiating chorea causes.
    • Basal ganglia dysfunction, beyond Huntington's disease, can manifest as transient or permanent chorea.